Article

Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals in the Indo-Pacific

2023-10-27

Abstract excerpt

<h4>Background</h4> Decision-makers in middle-income countries need evidence on the cost-effectiveness of COVID-19 booster doses and oral antivirals to appropriately prioritise these healthcare interventions. <h4>Methods</h4> We used a dynamic transmission model to assess the cost-effectiveness of COVID-19 booster doses and oral antivirals in Fiji, Indonesia, Papua New Guinea, and Timor-Leste. We conducted cost-ef...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8755376c-e2b1-563f-b449-37022eac89cc
DOI: 10.1101/2023.10.26.23297613

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals in the Indo-PacificDOI 10.1101/2023.10.26.23297613Read

The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South AfricaSemantic proximity Read

Standardized country-level delivery unit cost estimates for routine childhood, routine adolescent, and campaign vaccination: an updated modeling analysisSemantic proximity Read

Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in KenyaSemantic proximity Read

Economic Burden and Return on Investment of Immunization Programs in Saudi Arabia: A Health Economic EvaluationSemantic proximity Read

Estimated global cost of treating COVID-19, HIV, Hepatitis B and Hepatitis C with approved effective oral medicationsSemantic proximity Read

COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectivenessSemantic proximity Read

Opportunities for cost reduction of current first-line WHO-recommended oral antiretroviral therapy: replacing tenofovir disoproxil fumarate with tenofovir alafenamideSemantic proximity Read

Comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India: a modelling studySemantic proximity Read

Cost-effectiveness of Oral Regimens for Adolescents With Chronic Hepatitis C Virus Infection.Semantic proximity Read

Cost-effectiveness and cost-utility of COVID-19 vaccination in a South African privately insured population: a real-world claims-based analysisSemantic proximity Read

Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa.Semantic proximity Read

Cost and cost-effectiveness of Hepatitis C virus self-testing in four settings: an economic evaluationSemantic proximity Read